Antibody targeting of glioblastoma shows promise in preclinical tests

Cancer researchers at Georgetown University's Lombardi Comprehensive Cancer Centre have successfully tested a small, engineered antibody they say shuts down growth of human glioblastoma tumours in cell and animal studies. Glioblastoma is the deadliest of brain cancers; there is no effective treatment...

Read the whole article on

More from